University of Washington
Seattle, Washington, 98195, United States
NCT Number: NCT03117660
Prospective drug interaction study during pregnancy.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Phase 1
Seattle, Washington, 98195, United States
A randomized pharmacokinetic study to evaluate CYP2D6 activity with and without vitamin A administration during pregnancy and compared to postpartum control.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
vitamin A daily X3-4 weeks
Time frame: 4 weeks
dextromethorphan metabolic ratio change from baseline during pregnancy
University of Washington
Other
Effects of Retinoids on CYP2D6 Activity and Variability in Special Populations
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03076021
CYP2D6 Polymorphism
Seattle, Washington, United States
View Trial DetailsNCT02664350
CYP2D6 Polymorphism, Neurologic Manifestations
Gainesville, Florida, United States
View Trial DetailsNCT03411759
Agnosia, Analgesia
Bologna, Italy
View Trial DetailsNCT02428660
CYP2D6 Polymorphism, Chemically-Induced Disorders
Salt Lake City, Utah, United States
View Trial Details